EyePoint Pharmaceuticals

Filed a patent for "injector for delivering implants" on Fri, July 8, 2022

Filed a patent for "injector for delivering implants" on Thu, April 6, 2023

Filed a patent for "method of treating wet age-related macular degeneration" on Mon, October 31, 2022

Filed a patent for "methods of treating acute respiratory distress syndrome with activators of tie-2" on Thu, November 17, 2022

Filed a patent for "continuous dosing regimen for treatment of a condition of the eye" on Thu, March 17, 2022

Filed a patent for "method of treating wet age-related macular degeneration" on Thu, March 17, 2022

Filed a patent for "bioerodible drug delivery devices" on Thu, June 30, 2022

Filed a patent for "continuous dosing regimen for treatment of a condition of the eye" on Fri, May 13, 2022

Filed a patent for "continuous dosing regimen for treatment of a condition of the eye" on Mon, July 18, 2022

Filed a patent for "method of preventing age-related macular degeneration by administering an ocular drug delivery insert" on Mon, July 18, 2022

Filed a patent for "sustained release dexamethasone formulation" on Thu, March 16, 2023

Filed a patent for "bioerodible drug delivery devices" on Thu, March 30, 2023